1. Home
  2. ASTC vs CDT Comparison

ASTC vs CDT Comparison

Compare ASTC & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTC
  • CDT
  • Stock Information
  • Founded
  • ASTC 1984
  • CDT 2019
  • Country
  • ASTC United States
  • CDT United States
  • Employees
  • ASTC N/A
  • CDT N/A
  • Industry
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTC Industrials
  • CDT Health Care
  • Exchange
  • ASTC Nasdaq
  • CDT Nasdaq
  • Market Cap
  • ASTC 11.9M
  • CDT 10.9M
  • IPO Year
  • ASTC 1995
  • CDT N/A
  • Fundamental
  • Price
  • ASTC $7.70
  • CDT $0.10
  • Analyst Decision
  • ASTC
  • CDT
  • Analyst Count
  • ASTC 0
  • CDT 0
  • Target Price
  • ASTC N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • ASTC 17.7K
  • CDT 36.8M
  • Earning Date
  • ASTC 11-12-2024
  • CDT 11-14-2024
  • Dividend Yield
  • ASTC N/A
  • CDT N/A
  • EPS Growth
  • ASTC N/A
  • CDT N/A
  • EPS
  • ASTC N/A
  • CDT N/A
  • Revenue
  • ASTC $1,273,000.00
  • CDT N/A
  • Revenue This Year
  • ASTC N/A
  • CDT N/A
  • Revenue Next Year
  • ASTC N/A
  • CDT N/A
  • P/E Ratio
  • ASTC N/A
  • CDT N/A
  • Revenue Growth
  • ASTC 11.96
  • CDT N/A
  • 52 Week Low
  • ASTC $6.56
  • CDT $0.08
  • 52 Week High
  • ASTC $12.29
  • CDT $7.83
  • Technical
  • Relative Strength Index (RSI)
  • ASTC 56.01
  • CDT 50.24
  • Support Level
  • ASTC $6.99
  • CDT $0.08
  • Resistance Level
  • ASTC $7.47
  • CDT $0.16
  • Average True Range (ATR)
  • ASTC 0.44
  • CDT 0.02
  • MACD
  • ASTC 0.12
  • CDT 0.00
  • Stochastic Oscillator
  • ASTC 86.36
  • CDT 28.00

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: